Year |
Citation |
Score |
2020 |
Zamek-Gliszczynski MJ, Patel M, Yang X, Lutz JD, Chu X, Brouwer KLR, Lai Y, Lee CA, Neuhoff S, Paine MF, Sugiyama Y, Taskar KS, Galetin A. Intestinal P-gp and Putative Hepatic OATP1B Induction: ITC Perspective on Drug Development Implications. Clinical Pharmacology and Therapeutics. PMID 32460379 DOI: 10.1002/Cpt.1916 |
0.303 |
|
2019 |
Patel M, Eberl HC, Wolf A, Pierre E, Polli JW, Zamek-Gliszczynski MJ. Mechanistic basis of cabotegravir-glucuronide disposition in humans. The Journal of Pharmacology and Experimental Therapeutics. PMID 31175220 DOI: 10.1124/Jpet.119.258384 |
0.385 |
|
2018 |
Patel M, Johnson M, Sychterz CJ, Lewis GJ, Watson C, Ellens H, Polli JW, Zamek-Gliszczynski MJ. Hepatobiliary disposition of atovaquone: A case of mechanistically unusual biliary clearance. The Journal of Pharmacology and Experimental Therapeutics. PMID 29653960 DOI: 10.1124/Jpet.117.247254 |
0.415 |
|
2016 |
Patel M, Taskar KS, Zamek-Gliszczynski MJ. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites. Journal of Clinical Pharmacology. 56: S23-S39. PMID 27385177 DOI: 10.1002/Jcph.671 |
0.364 |
|
2015 |
Mandal A, Patel M, Sheng Y, Mitra AK. Design of lipophilic prodrugs to improve drug delivery and efficacy. Current Drug Targets. PMID 26648076 DOI: 10.2174/1389450117666151209115431 |
0.566 |
|
2014 |
Patel M, Sheng Y, Mandava NK, Pal D, Mitra AK. Dipeptide prodrug approach to evade efflux pumps and CYP3A4 metabolism of lopinavir. International Journal of Pharmaceutics. 476: 99-107. PMID 25261710 DOI: 10.1016/J.Ijpharm.2014.09.035 |
0.747 |
|
2014 |
Patel A, Patel M, Yang X, Mitra AK. Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles. Protein and Peptide Letters. 21: 1102-20. PMID 25106908 DOI: 10.2174/0929866521666140807114240 |
0.475 |
|
2014 |
Patel M, Mandava N, Gokulgandhi M, Pal D, Mitra AK. Amino Acid Prodrugs: An Approach to Improve the Absorption of HIV-1 Protease Inhibitor, Lopinavir. Pharmaceuticals (Basel, Switzerland). 7: 433-52. PMID 24727459 DOI: 10.3390/Ph7040433 |
0.711 |
|
2014 |
Vadlapatla RK, Patel M, Paturi DK, Pal D, Mitra AK. Clinically relevant drug-drug interactions between antiretrovirals and antifungals. Expert Opinion On Drug Metabolism & Toxicology. 10: 561-80. PMID 24521092 DOI: 10.1517/17425255.2014.883379 |
0.691 |
|
2014 |
Patel M, Mandava NK, Pal D, Mitra AK. Amino acid prodrug of quinidine: an approach to circumvent P-glycoprotein mediated cellular efflux. International Journal of Pharmaceutics. 464: 196-204. PMID 24440401 DOI: 10.4172/2155-9570.S1.018 |
0.752 |
|
2013 |
Patel M, Mandava NK, Vadlapatla RK, Mitra AK. Recent patents and emerging therapeutics for HIV infections: a focus on protease inhibitors. Pharmaceutical Patent Analyst. 2: 513-38. PMID 24237127 DOI: 10.4155/Ppa.13.33 |
0.7 |
|
2013 |
Patel M, Dalvi P, Gokulgandhi M, Kesh S, Kohli T, Pal D, Mitra AK. Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells. International Journal of Pharmaceutics. 443: 245-53. PMID 23270998 DOI: 10.1016/J.Ijpharm.2012.12.029 |
0.77 |
|
2012 |
Patel M, Vadlapatla RK, Shah S, Mitra AK. Molecular expression and functional activity of sodium dependent multivitamin transporter in human prostate cancer cells. International Journal of Pharmaceutics. 436: 324-31. PMID 22732670 DOI: 10.1016/J.Ijpharm.2012.06.011 |
0.743 |
|
2012 |
Patel M, Vadlapatla RK, Pal D, Mitra AK. Molecular and functional characterization of riboflavin specific transport system in rat brain capillary endothelial cells. Brain Research. 1468: 1-10. PMID 22683359 DOI: 10.1016/J.Brainres.2012.05.052 |
0.741 |
|
2011 |
Luo S, Wang Z, Patel M, Khurana V, Zhu X, Pal D, Mitra AK. Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir. International Journal of Pharmaceutics. 414: 77-85. PMID 21571053 DOI: 10.1016/J.Ijpharm.2011.05.001 |
0.75 |
|
Show low-probability matches. |